Global Expansion UE LifeSciences is a fast-growing multinationals med-tech company with products like iBreastExam and cervAIcal reaching over 250,000 women across 12 countries, presenting opportunities to engage regional distributors and healthcare providers in new markets.

Revenue Growth Revenue has risen five-fold in the last three years, indicating increasing market adoption and potential willingness to expand procurement partnerships, training programs, and after-sales services with health systems and clinics.

Funding & Awards With over $6 million raised in grants, equity capital, and awards, plus recognition from platforms like TED Talks and major outlets, there is credibility to leverage in outreach to potential funders, insurers, and government programs for expanded adoption.

Strategic Partnerships Recent collaborations and partnerships with Molbio Diagnostics and media coverage suggest a willingness to co-develop and co-market; identify joint go-to-market opportunities, channel partnerships, and regional distribution deals to accelerate penetration.

Clinical & Advisory Strength Strong clinical guidance through a Medical Advisory Board and engagement in major conferences like World Cancer Congress signal opportunities to position UE LifeSciences as a preferred partner for hospital networks, cancer centers, and screening programs seeking validated screening technologies.